Comprehensive GI portfolio covering antispasmodics, acid reducers, and liver disease APIs.
Pantoprazole Gastro-Resistant Tablets (40mg)
Rabeprazole Sodium (20mg) + Domperidone SR (30mg)
Sulfasalazine Gastro-Resistant Tablets (500mg, 1000mg)
Each uncoated tablet contains Diphenoxylate Hydrochloride IP 2.5mg + Atropine Sulphate IP 0.025mg
Lafutidine Tablets (10mg)
Each capsule contains Rebeprazole Sodium (as enteric coated pellets) Domperidone IP 30mg as sustained release pellets
Mycophenolate Sodium Enteric Coated (180mg, 360mg)
Each Enteric coated tablet contains Reaperazole Sodium IP 20mg
